Your browser doesn't support javascript.
loading
Multiple lung cancers including squamous cell carcinoma with strong PD-L1 expression and adenocarcinoma with EGFR exon 19 deletion: A case report.
Tokuyasu, Hirokazu; Horie, Mika; Ishikawa, Soichiro; Sakai, Hiromitsu; Miura, Hiroshi; Yamasaki, Akira.
Afiliação
  • Tokuyasu H; Divisions of Respiratory Medicine, Matsue Red Cross Hospital, Shimane, Japan.
  • Horie M; Divisions of Respiratory Medicine, Matsue Red Cross Hospital, Shimane, Japan.
  • Ishikawa S; Divisions of Respiratory Medicine, Matsue Red Cross Hospital, Shimane, Japan.
  • Sakai H; Divisions of Respiratory Medicine, Matsue Red Cross Hospital, Shimane, Japan.
  • Miura H; Pathology, Matsue Red Cross Hospital, Shimane, Japan.
  • Yamasaki A; Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
Respir Med Case Rep ; 29: 100976, 2020.
Article em En | MEDLINE | ID: mdl-31886125
We herein report a non-smoking 81-year-old man with advanced synchronous multiple primary lung cancers (SMPLC), containing squamous cell carcinoma with strong programmed death-ligand 1 expression in the middle lobe and adenocarcinoma with epidermal growth factor receptor (EGFR) exon 19 deletion in the lower lobe. Programmed death-1 (PD-1) inhibitors were administered as first-line chemotherapy; however, treatment response was poor response. There have been no reported SMPLC cases similar to this. During treatment, his non-smoking status and EGFR deletion might have been the cause of the patient's poor response to first-line PD-1 inhibitor treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Respir Med Case Rep Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Respir Med Case Rep Ano de publicação: 2020 Tipo de documento: Article